228 related articles for article (PubMed ID: 3307670)
1. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R
Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670
[TBL] [Abstract][Full Text] [Related]
2. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial.
McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C
Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
4. Do endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease?
Robinson MG; Orr WC; McCallum R; Nardi R
Am J Gastroenterol; 1987 Jun; 82(6):519-22. PubMed ID: 3554990
[TBL] [Abstract][Full Text] [Related]
5. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Farley A; Wruble LD; Humphries TJ
Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
[TBL] [Abstract][Full Text] [Related]
6. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease.
Sherbaniuk R; Wensel R; Bailey R; Trautman A; Grace M; Kirdeikis P; Jewell L; Pare P; Levesque D; Farley A
J Clin Gastroenterol; 1984 Feb; 6(1):9-15. PubMed ID: 6321588
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
Behar J; Brand DL; Brown FC; Castell DO; Cohen S; Crossley RJ; Pope CE; Winans CS
Gastroenterology; 1978 Feb; 74(2 Pt 2):441-8. PubMed ID: 340333
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG
Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
10. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
[TBL] [Abstract][Full Text] [Related]
11. Cisapride versus ranitidine in the treatment of reflux esophagitis.
Janisch HD; Hüttemann W; Bouzo MH
Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
[TBL] [Abstract][Full Text] [Related]
12. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
13. Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide.
Orr WC; Finn A; Wilson T; Russell J
Am J Gastroenterol; 1990 Jun; 85(6):697-700. PubMed ID: 2191595
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
15. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
Kahrilas PJ; Fennerty MB; Joelsson B
Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
[TBL] [Abstract][Full Text] [Related]
16. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.
Petrokubi RJ; Jeffries GH
Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093
[TBL] [Abstract][Full Text] [Related]
17. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
[TBL] [Abstract][Full Text] [Related]
18. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
19. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group.
Sabesin SM; Berlin RG; Humphries TJ; Bradstreet DC; Walton-Bowen KL; Zaidi S
Arch Intern Med; 1991 Dec; 151(12):2394-400. PubMed ID: 1746996
[TBL] [Abstract][Full Text] [Related]
20. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
Richter JE; Long JF
Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
